Heron Therapeutics | HRTX - EPS Earnings Per Share


Heron Therapeutics reported $-0.02 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
ALKERMES USD -0.4 0.69 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amarin USD 0.14 0.06 Dec/2025
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -0.93 1.15 Mar/2026
Eisai JPY -11.53 72.47 Mar/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.76 0.78 Mar/2026
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.6 0.54 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Veracyte USD 0.52 0.01 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026